StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.24+0.24 (+12.00%)

Close on Nov 18, 2026Market cap $101.35MP/E –Yield –

Genelux market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Genelux's market cap was $84.79M on Nov 11, 2026, against $211.54M a year earlier. Over the last 4 years it ranged from $52.64M to $803.39M, with a median of $131.83M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$84.79M-48.9%
2025Dec 31, 2025$165.88M+103.5%
2024Dec 31, 2024$81.51M-78.2%
2023Dec 29, 2023$373.48M–

More Genelux figures

See a number that looks wrong?